More answers like this
GPT-5Oct 9, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Short answer: a blanket pause on all AI development isn’t practical or desirable; targeted restrictions and, when needed, time‑bound moratoria on specific high‑risk capabilities make more sense.
Why some argue for a pause
•Fast capability scaling with uncertain failure modes (bio, cyber, persuasion, autonomy).
•Race dynamics that can undercut safety practices.
•Externalities that individual firms can’t manage alone.
Why a blanket pause can backfire
•Hard to verify and enforce globally; work may shift to less regulated venues.
•Freezes beneficial uses and safety research alongside risky capability work.
•Entrenches incumbents with existing models and compute.
A better path: restrict by risk, with clear triggers for pausing
•Licensing by compute threshold: require approval, audit trails, and monitoring for training runs above defined FLOP or model‑size limits.
•Mandatory pre‑deployment evaluations: standardized red‑teaming for bio, cyber, model autonomy/replication, targeted persuasion, and model‑steering resistance; no release until models pass agreed thresholds.
•Secure model handling: weight security, restricted access to high‑risk weights, rate limits, logging, and provenance/watermarking of outputs where feasible.
•Phased release and oversight: staged rollouts, independent audits, incident reporting with safe‑harbor protections, and recall/kill‑switch plans.
•Liability and product‑safety duties: clear accountability for foreseeable harms; require post‑deployment monitoring and patching.
•International coordination: interoperable standards, shared evals, and measures against compute diversion; export controls targeted at frontier training, not everyday uses.
•Sunset and review: restrictions auto‑reassessed on a fixed schedule so rules keep pace with evidence.
When a true pause is warranted
•Credible evidence of capabilities like: automated design of novel biological agents or dangerous chemistries; autonomous replication or large‑scale social manipulation; systematic jailbreak resistance failure; or major real‑world safety incidents. In these cases, impose a short, verifiable moratorium on scaling beyond current capability until mitigations are demonstrated.
What not to restrict broadly
•Low‑risk applications, safety/alignment research, transparency work, and education. Regulate deployment risk, not research per se.
Bottom line: Don’t pause everything. Do enforce capability‑based restrictions with measurable evals, independent oversight, and clear off‑ramps for safe progress.
If you’re thinking about this for policy, a debate, or company practice, tell me your context and I can tailor a concrete plan or talking points.